Peifeng Hou

Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2

Peifeng Hou, Ching‐Ying Kuo, Chun-Ting Cheng et al. · PLoS ONE · 2014 · 45 citations · Full text

Medicine, Biochemistry, Oncology +16

Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study

Linbin Lu, Lujun Shen, Zhixian Wu et al. · EClinicalMedicine · 2022 · 31 citations · Full text

Medicine, Biostatistics, Oncology +16

HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity

Ching‐Ying Kuo, Chun-Ting Cheng, Peifeng Hou et al. · Oncotarget · 2016 · 29 citations · Full text

Life Sciences, Cell Biology, Oncology +17

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Chunyue Wang, Zhenlong Zhang, Yulan Sun et al. · Journal of Translational Medicine · 2022 · 22 citations · Full text

Medicine, Genetics, Oncology +17

<i>PRPS2</i> Enhances Resistance to Cisplatin via Facilitating Exosomes-mediated Macrophage M2 Polarization in Non-small Cell Lung Cancer

Gaohua Liu, Yang Luo, Peifeng Hou · Immunological Investigations · 2021 · 21 citations

Medicine, Cancer Biology, Oncology +17